New patent for Astrazeneca Ab drug BYDUREON

Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…
The post New patent for Astrazeneca Ab drug BYDUREON appeared first on D…


Which pharmaceutical companies have the most SPCs in Luxembourg?

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Luxembourg. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceuti…


Biotechblog